183 related articles for article (PubMed ID: 29803870)
21. Evaluating N-acetylcysteine for early and end-of-treatment abstinence in adult cigarette smokers.
McClure EA; Wahlquist AE; Tomko RL; Baker NL; Carpenter MJ; Bradley ED; Cato PA; Gipson CD; Gray KM
Drug Alcohol Depend; 2021 Aug; 225():108815. PubMed ID: 34171822
[TBL] [Abstract][Full Text] [Related]
22. Gender differences among treatment-seeking adults with cannabis use disorder: Clinical profiles of women and men enrolled in the achieving cannabis cessation-evaluating N-acetylcysteine treatment (ACCENT) study.
Sherman BJ; McRae-Clark AL; Baker NL; Sonne SC; Killeen TK; Cloud K; Gray KM
Am J Addict; 2017 Mar; 26(2):136-144. PubMed ID: 28152236
[TBL] [Abstract][Full Text] [Related]
23. Examining Associations Between Cannabis Use Disorder and Measures of Weekly and Within-Day Cannabis Frequency, Quantity, and Potency in College Students.
Piercey CJ; Mataczynski M; Stallsmith VT; Emery NN; Karoly HC
Cannabis Cannabinoid Res; 2024 Jun; 9(3):e917-e923. PubMed ID: 37699241
[No Abstract] [Full Text] [Related]
24. N-Acetylcysteine for Nonsuicidal Self-Injurious Behavior in Adolescents: An Open-Label Pilot Study.
Cullen KR; Klimes-Dougan B; Westlund Schreiner M; Carstedt P; Marka N; Nelson K; Miller MJ; Reigstad K; Westervelt A; Gunlicks-Stoessel M; Eberly LE
J Child Adolesc Psychopharmacol; 2018 Mar; 28(2):136-144. PubMed ID: 29053023
[TBL] [Abstract][Full Text] [Related]
25. Is There a Place for Off-Label Pharmacotherapy in Cannabis Use Disorder? A Review on Efficacy and Safety.
Laprevote V; Schwan R; Schwitzer T; Rolland B; Thome J
Curr Pharm Des; 2015; 21(23):3298-305. PubMed ID: 26088109
[TBL] [Abstract][Full Text] [Related]
26. N-acetyl cysteine in the treatment of cannabis use disorder: A systematic review of clinical trials.
Sharma R; Tikka SK; Bhute AR; Bastia BK
Addict Behav; 2022 Jun; 129():107283. PubMed ID: 35189496
[TBL] [Abstract][Full Text] [Related]
27. N-acetylcysteine in the treatment of psychiatric disorders: current status and future prospects.
Minarini A; Ferrari S; Galletti M; Giambalvo N; Perrone D; Rioli G; Galeazzi GM
Expert Opin Drug Metab Toxicol; 2017 Mar; 13(3):279-292. PubMed ID: 27766914
[TBL] [Abstract][Full Text] [Related]
28. Dronabinol and lofexidine for cannabis use disorder: A randomized, double-blind, placebo-controlled trial.
Levin FR; Mariani JJ; Pavlicova M; Brooks D; Glass A; Mahony A; Nunes EV; Bisaga A; Dakwar E; Carpenter KM; Sullivan MA; Choi JC
Drug Alcohol Depend; 2016 Feb; 159():53-60. PubMed ID: 26711160
[TBL] [Abstract][Full Text] [Related]
29. Marijuana craving trajectories in an adolescent marijuana cessation pharmacotherapy trial.
Roten AT; Baker NL; Gray KM
Addict Behav; 2013 Mar; 38(3):1788-91. PubMed ID: 23261493
[TBL] [Abstract][Full Text] [Related]
30. N-acetylcysteine for depression and glutamate changes in the left prefrontal cortex in adolescents and young adults at risk for bipolar disorder: A pilot study.
Nery FG; Tallman MJ; Cecil KM; Blom TJ; Patino LR; Adler CM; DelBello MP
Early Interv Psychiatry; 2022 Feb; 16(2):195-199. PubMed ID: 33797205
[TBL] [Abstract][Full Text] [Related]
31. Who responds best to text-delivered cannabis use disorder treatment? A randomized clinical trial with young adults.
Mason MJ; Zaharakis NM; Moore M; Brown A; Garcia C; Seibers A; Stephens C
Psychol Addict Behav; 2018 Nov; 32(7):699-709. PubMed ID: 30265057
[TBL] [Abstract][Full Text] [Related]
32. Randomized controlled trial of
Todd JJ; Lawal TA; Witherspoon JW; Chrismer IC; Razaqyar MS; Punjabi M; Elliott JS; Tounkara F; Kuo A; Shelton MO; Allen C; Cosgrove MM; Linton M; Michael D; Jain MS; Waite M; Drinkard B; Wakim PG; Dowling JJ; Bönnemann CG; Emile-Backer M; Meilleur KG
Neurology; 2020 Mar; 94(13):e1434-e1444. PubMed ID: 31941795
[TBL] [Abstract][Full Text] [Related]
33. [The application of n-acetylcysteine as an antioxidant and mucolytic in mechanical ventilation in intensive care patients. A prospective, randomized, placebo-controlled, double-blind study].
Konrad F; Schoenberg MH; Wiedmann H; Kilian J; Georgieff M
Anaesthesist; 1995 Sep; 44(9):651-8. PubMed ID: 7485927
[TBL] [Abstract][Full Text] [Related]
34. Nail-biting stuff? The effect of N-acetyl cysteine on nail-biting.
Berk M; Jeavons S; Dean OM; Dodd S; Moss K; Gama CS; Malhi GS
CNS Spectr; 2009 Jul; 14(7):357-60. PubMed ID: 19773711
[TBL] [Abstract][Full Text] [Related]
35. Design and rationale of a 16-week adjunctive randomized placebo-controlled trial of mitochondrial agents for the treatment of bipolar depression.
Dean OM; Turner A; Malhi GS; Ng C; Cotton SM; Dodd S; Sarris J; Samuni Y; Tanious M; Dowling N; Waterdrinker A; Smith D; Berk M
Braz J Psychiatry; 2015; 37(1):3-12. PubMed ID: 25295681
[TBL] [Abstract][Full Text] [Related]
36. N-acetylcysteine as add-on to antidepressant medication in therapy refractory major depressive disorder patients with increased inflammatory activity: study protocol of a double-blind randomized placebo-controlled trial.
Yang C; Bosker FJ; Li J; Schoevers RA
BMC Psychiatry; 2018 Sep; 18(1):279. PubMed ID: 30176835
[TBL] [Abstract][Full Text] [Related]
37. Treatment of Cannabis Use Disorder: Current Science and Future Outlook.
Sherman BJ; McRae-Clark AL
Pharmacotherapy; 2016 May; 36(5):511-35. PubMed ID: 27027272
[TBL] [Abstract][Full Text] [Related]
38. The efficacy of adjunctive N-acetylcysteine in acute bipolar depression: A randomized placebo-controlled study.
Ellegaard PK; Licht RW; Nielsen RE; Dean OM; Berk M; Poulsen HE; Mohebbi M; Nielsen CT
J Affect Disord; 2019 Feb; 245():1043-1051. PubMed ID: 30699846
[TBL] [Abstract][Full Text] [Related]
39. Efficacy and safety of a fatty acid amide hydrolase inhibitor (PF-04457845) in the treatment of cannabis withdrawal and dependence in men: a double-blind, placebo-controlled, parallel group, phase 2a single-site randomised controlled trial.
D'Souza DC; Cortes-Briones J; Creatura G; Bluez G; Thurnauer H; Deaso E; Bielen K; Surti T; Radhakrishnan R; Gupta A; Gupta S; Cahill J; Sherif MA; Makriyannis A; Morgan PT; Ranganathan M; Skosnik PD
Lancet Psychiatry; 2019 Jan; 6(1):35-45. PubMed ID: 30528676
[TBL] [Abstract][Full Text] [Related]
40. Prolonged cannabis withdrawal in young adults with lifetime psychiatric illness.
Schuster RM; Fontaine M; Nip E; Zhang H; Hanly A; Evins AE
Prev Med; 2017 Nov; 104():40-45. PubMed ID: 28242263
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
